Development of an AIDS vaccine using Sendai virus vectors

被引：16
|
作者：
Ishii, Hiroshi [1 ]
Matano, Tetsuro [1 ,2 ]
机构：
[1] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan
[2] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan
来源：
VACCINE | 2015年 / 33卷 / 45期
关键词：
AIDS vaccine; Sendai virus vector; HIV; SIV; CD4(+) T-CELLS; LYMPHOCYTE-BASED CONTROL; IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; HIV-1; VACCINE; REPLICATION; INFECTION; IMMUNOGENICITY;
D O I：
10.1016/j.vaccine.2015.06.114
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Development of an effective AIDS vaccine is crucial for the control of global human immunodeficiency virus type 1 (HIV-1) prevalence. We have developed a novel AIDS vaccine using a Sendai virus (SeV) vector and investigated its efficacy in a macaque AIDS model of simian immunodeficiency virus (SIV) infection. Its immunogenicity and protective efficacy have been shown, indicating that the SeV vector is a promising delivery tool for AIDS vaccines. Here, we describe the potential of SeV vector as a vaccine antigen delivery tool to induce effective immune responses against HIV-1 infection. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6061 / 6065
页数：5
相关论文
共 50 条
  • [31] Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles
    Kang, CY
    Luo, LZ
    Wainberg, MA
    Li, Y
    [J]. BIOLOGICAL CHEMISTRY, 1999, 380 (03) : 353 - 364
  • [32] Development of novel vaccine vectors: Chimpanzee adenoviral vectors
    Guo, Jingao
    Mondal, Moumita
    Zhou, Dongming
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (07) : 1679 - 1685
  • [33] ACCELERATING THE DEVELOPMENT OF AN AIDS VACCINE: THE AIDS VACCINE FOR ASIA NETWORK (AVAN)
    Pitisuttithum, Punnee
    Rerks-Ngarm, Supachai
    Chiu, Joseph
    Kim, Jerome
    Benenson, Michael
    Kent, Stephen J.
    Tamashiro, Hiko
    Manrique, Amapola
    Bernstein, Alan
    Goyal, Rajat
    Ditangco, Rossana A.
    Cooper, David A.
    Osmanov, Saladin
    Mathieson, Bonnie
    Sandstrom, Eric
    Esparza, Jose
    Hoff, Rodney
    Shao, Yiming
    [J]. SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (05) : 1130 - 1146
  • [34] Vaccine for AIDS and Ebola virus infection
    Nabel, GJ
    [J]. VIRUS RESEARCH, 2003, 92 (02) : 213 - 217
  • [35] DEVELOPMENT OF ANTIBODIES AGAINST SENDAI VIRUS IN CHILDHOOD
    STARK, JE
    HEATH, RB
    [J]. ARCHIV FUR DIE GESAMTE VIRUSFORSCHUNG, 1967, 20 (04): : 438 - +
  • [36] Rational Vaccine Design and the Development of an AIDS Vaccine
    Nabel, Gary J.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 103 - 103
  • [37] The potential of plant virus vectors for vaccine production
    Yusibov V.
    Rabindran S.
    Commandeur U.
    Twyman R.M.
    Fischer R.
    [J]. Drugs in R & D, 2006, 7 (4) : 203 - 217
  • [38] The Development of an AIDS Mucosal Vaccine
    Tang, Xian
    Chen, Zhiwei
    [J]. VIRUSES-BASEL, 2010, 2 (01): : 283 - 297
  • [39] PROGRESS IN AIDS VACCINE DEVELOPMENT
    JOHNSTON, MI
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 108 (04) : 313 - 317
  • [40] Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model
    Takeda, A
    Igarashi, H
    Nakamura, H
    Kano, M
    Iida, A
    Hirata, T
    Hasegawa, M
    Nagai, Y
    Matano, T
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (17) : 9710 - 9715
12345